Consultant Gynaecologist & Professor of Gynaecology Unit at Liaquat University of Medical and Health Sciences (LUMHS), Prof. Chandra Madhu Das said said around the world, breast cancer statistics showed that after lung cancer breast cancer was the second most death-causing factor in people. Breast cancer is the the most frequent malignancy among women in Pakistan [...]
Chemotherapy can have many unpleasant side effects, one of which is oral Mucositis: mouth sores or ulcers that develop on the soft tissues of your lips, mouth, gums, and tongue, and, in some cases, extend into the esophagus. Not every patient will develop mouth sores from chemotherapy, but if you do, there are steps you [...]
Dr. Muhammad Najeeb Durrani, Epidemiologist, District Surveillance Coordinator, District TB Coordinator (DTC), In-charge Dengue Fever Surveillance Cell, Islamabad Although the Government of Pakistan’s National TB Control Program through its TB DOTS strategy has revolutionized the TB treatment in the country and brought down the incidence and the prevalence of disease thereby improving the treatment indicators; [...]
By Dr. Chaudhry Qasim Mahmood Buttar, Oncologist, Pakistan Institute of Medical Sciences, Islamabad Kidney cancer, of which the most common type is Renal Cell Carcinoma, is a type of cancer that starts in the kidneys. It is among the ten most common cancers in the world, although the risk is higher in men than in [...]
Health Robotics announced a new marketing and service channel for its world-leading i.v.STATION ONCO, i.v.SOFT, and i.v.STATION products with Kingdom of Saudi Arabia-based market leader Hospital Automation Technology (HAT). Health Robotics continues to spearhead the global healthcare industry and persisting on its worldwide quest to provide safe and cost-effective Intravenous Admixture Compounding Automation all over [...]
Health Robotics today announced FY2011 audited financial results, once again delivering record levels of revenues, gross margins, EBITDA, and profits, while concurrently weathering the economic world crisis, unfavorable Euro/Dollar exchange rates, and successfully defeating hostile takeover attempts and groundless lawsuits. Gaspar DeViedma, Health Robotics’ Executive Vice President, stated: “FY2011 revenues reached almost $18M (a [...]
Cabozantinib, a medication for the treatment of medullary thyroid cancer, has shown promising results in final-stage testing. Until now, there was no medication available in Belgium for treating this rare form of thyroid cancer. Dr. Patrick Schöffski, professor of oncology at the University of Leuven (KU Leuven), presented the results at the annual meeting of [...]
Health Robotics today announced that it recently signed an exclusive distribution agreement for its CytoCare, i.v.STATION, and i.v.SOFT world-leading technologies with Israel-based medical technology leader Gamida MedEquip Ltd. This partnership represents Health Robotics’ market entry into its 17th new country over the past 20 months, persisting on its worldwide quest to pervasively provide safe and [...]
Health Robotics today announced the official opening and live operation of the largest Sterile Compounding Center for Oncology patients in the world. Akdeniz University Hospital in Antalya (Turkey) compounds 90% of its 80.000 annual chemotherapy intravenous doses with 4 CytoCare robots and related Health Robotics’ technology, or an average of 325 patient doses per 6-hour [...]
